|
| Qing tumor glutaminase for therapy |
|
https://doi.org/10.18632/oncotarget.6301
Zachary E. Stine, and Chi V. Dang
|
| 38440-38441 |
|
| Mitochondrial mass and DNA repair in breast cancer stem cells |
|
https://doi.org/10.18632/oncotarget.6305
Richard G. Pestell, Alesandro Fatatis, and Xuanmao Jiao
|
| 38442-38443 |
|
| Inflammasome effects in GvHD |
|
https://doi.org/10.18632/oncotarget.6307
Brent H. Koehn, Robert Zeiser, and Bruce R. Blazar
|
| 38444-38445 |
|
| Glucocorticoidinduced leucine zipper GILZ in immuno suppression: master regulator or bystander |
|
https://doi.org/10.18632/oncotarget.6197
Jessica Hoppstädter, and Alexandra K. Kiemer
|
| 38446-38457 |
|
| Intermittent highdose treatment with erlotinib enhances therapeutic efficacy in EGFRmutant lung cancer |
|
https://doi.org/10.18632/oncotarget.6276
Jakob Schöttle, Sampurna Chatterjee, Caroline Volz, Maike Siobal, Alexandra Florin, Dennis Rokitta, Yvonne Hinze, Felix Dietlein, Dennis Plenker, Katharina König, Kerstin Albus, Johannes M. Heuckmann, Daniel Rauh, Thomas Franz, Bernd Neumaier, Uwe Fuhr, Lukas C. Heukamp, and Roland T. Ullrich
|
| 38458-38468 |
|
| LIM kinase inhibitors disrupt mitotic microtubule organization and impair tumor cell proliferation |
|
https://doi.org/10.18632/oncotarget.6288
Katerina Mardilovich, Mark Baugh, Diane Crighton, Dominika Kowalczyk, Mads Gabrielsen, June Munro, Daniel R. Croft, Filipe Lourenco, Daniel James, Gabriella Kalna, Lynn McGarry, Oliver Rath, Emma Shanks, Mathew J. Garnett, Ultan McDermott, Joanna Brookfield, Mark Charles, Tim Hammonds, and Michael F. Olson
|
| 38469-38486 |
|
| An inducible transgenic mouse breast cancer model for the analysis of tumor antigen specific CD8+ Tcell responses |
|
https://doi.org/10.18632/oncotarget.5750
Michael Bruns, Jara Wanger, Olaf Utermöhlen, and Wolfgang Deppert
|
| 38487-38503 |
|
| Recombinant rabies virus expressing dog GMCSF is an efficacious oral rabies vaccine for dogs |
|
https://doi.org/10.18632/oncotarget.5904
Ming Zhou, Lei Wang, Songqin Zhou, Zhao Wang, Juncheng Ruan, Lijun Tang, Ziming Jia, Min Cui, Ling Zhao, and Zhen F. Fu
|
| 38504-38516 |
|
| PPE26 induces TLR2dependent activation of macrophages and drives Th1type Tcell immunity by triggering the crosstalk of multiple pathways involved in the host response |
|
https://doi.org/10.18632/oncotarget.5956
Haibo Su, Cong Kong, Lin Zhu, Qi Huang, Liulin Luo, Honghai Wang, and Ying Xu
|
| 38517-38537 |
|
| The cAMP response element modulator CREM regulates TH2 mediated inflammation |
|
https://doi.org/10.18632/oncotarget.6041
Eva Verjans, Kim Ohl, Lucy K. Reiss, Femke van Wijk, Antonaneta A. Toncheva, Anastasia Wiener, Yin Yu, Annette D. Rieg, Vincent D. Gaertner, Johannes Roth, Edward Knol, Michael Kabesch, Norbert Wagner, Stefan Uhlig, Christian Martin, and Klaus Tenbrock
|
| 38538-38551 |
|
| Chromosomal instability triggers cell death via local signalling through the innate immune receptor Toll |
|
https://doi.org/10.18632/oncotarget.6035
Dawei Liu, Zeeshan Shaukat, Robert B. Saint, and Stephen L. Gregory
|
| 38552-38565 |
|
| Decreased severity of collagen antibody and lipopolysaccharideinduced arthritis in human IL32β overexpressed transgenic mice |
|
https://doi.org/10.18632/oncotarget.6160
Mi Hee Park, Do-Young Yoon, Jung Ok Ban, Dae Hwan Kim, Dong Hun Lee, Sukgil Song, Youngsoo Kim, Sang-Bae Han, Hee Pom Lee, and Jin Tae Hong
|
| 38566-38577 |
|
| Hepatic TLR4 signaling is activated by LPS from digestive tract during SARA and epigenetic mechanisms contribute to enforced TLR4 expression |
|
https://doi.org/10.18632/oncotarget.6161
Guangjun Chang, Su Zhuang, Hans-Martin Seyfert, Kai Zhang, Tianle Xu, Di Jin, Junfei Guo, and Xiangzhen Shen
|
| 38578-38590 |
|
| MYCdriven aggressive Bcell lymphomas: biology entity differential diagnosis and clinical management |
|
https://doi.org/10.18632/oncotarget.5774
Qingqing Cai, L. Jeffrey Medeiros, Xiaolu Xu, and Ken H. Young
|
| 38591-38616 |
|
| Targeted cancer therapy with ribosome biogenesis inhibitors: a real possibility |
|
https://doi.org/10.18632/oncotarget.5775
Elisa Brighenti, Davide Treré, and Massimo Derenzini
|
| 38617-38627 |
|
| miRNA interventions serve as ‘magic bullets’ in the reversal of glioblastoma hallmarks |
|
https://doi.org/10.18632/oncotarget.5926
Luyue Chen, and Chunsheng Kang
|
| 38628-38642 |
|
| Detection of cancer through exhaled breath: a systematic review |
|
https://doi.org/10.18632/oncotarget.5938
Agne Krilaviciute, Jonathan Alexander Heiss, Marcis Leja, Juozas Kupcinskas, Hossam Haick, and Hermann Brenner
|
| 38643-38657 |
|
| Pattern of distant metastases in colorectal cancer: a SEER based study |
|
https://doi.org/10.18632/oncotarget.6130
Miaozhen Qiu, Jianming Hu, Dajun Yang, David Peter Cosgrove, and Ruihua Xu
|
| 38658-38666 |
|
| Hes1 promotes cell proliferation and migration by activating Bmi1 and PTEN/Akt/GSK3β pathway in human colon cancer |
|
https://doi.org/10.18632/oncotarget.5484
Fei Gao, Wei Huang, YuQin Zhang, ShaoHui Tang, Lin Zheng, Feng Ma, YiMing Wang, Hui Tang, and Xin Li
|
| 38667-38680 |
|
| Wholetranscriptome analysis of flowsorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival |
|
https://doi.org/10.18632/oncotarget.4526
Simone Punt, Willem E. Corver, Sander A.J. van der Zeeuw, Szymon M. Kielbasa, Elisabeth M. Osse, Henk P.J. Buermans, Cornelis D. de Kroon, Ekaterina S. Jordanova, and Arko Gorter
|
| 38681-38694 |
|
| MicroRNA expression profiling identifies miR315p/3p as associated with time to progression in wildtype RAS metastatic colorectal cancer treated with cetuximab |
|
https://doi.org/10.18632/oncotarget.5735
Jitka Mlcochova, Petra Faltejskova-Vychytilova, Manuela Ferracin, Barbara Zagatti, Lenka Radova, Marek Svoboda, Radim Nemecek, Stanislav John, Igor Kiss, Rostislav Vyzula, Massimo Negrini, and Ondrej Slaby
|
| 38695-38704 |
|
| microRNA214 promotes epithelialmesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressoroffused protein Sufu |
|
https://doi.org/10.18632/oncotarget.5478
Haixia Long, Zhongyu Wang, Junying Chen, Tong Xiang, Qijing Li, Xinwei Diao, and Bo Zhu
|
| 38705-38718 |
|
| A link between lipid metabolism and epithelialmesenchymal transition provides a target for colon cancer therapy |
|
https://doi.org/10.18632/oncotarget.5340
Ruth Sánchez-MartÃnez, Silvia Cruz-Gil, Marta Gómez de Cedrón, Mónica Ãlvarez-Fernández, Teodoro Vargas, Susana Molina, Belén GarcÃa, Jesús Herranz, Juan Moreno-Rubio, Guillermo Reglero, Mirna Pérez-Moreno, Jaime Feliu, Marcos Malumbres, and Ana RamÃrez de Molina
|
| 38719-38736 |
|
| Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: are all mutations equal |
|
https://doi.org/10.18632/oncotarget.5395
Elena Maccaroni, Raffaella Bracci, Riccardo Giampieri, Francesca Bianchi, Laura Belvederesi, Cristiana Brugiati, Silvia Pagliaretta, Michela Del Prete, Mario Scartozzi, and Stefano Cascinu
|
| 38737-38748 |
|
| Cytokeratin19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis |
|
https://doi.org/10.18632/oncotarget.5501
Marta Anna Kowalik, Pia Sulas, Giovanna Maria Ledda-Columbano, Silvia Giordano, Amedeo Columbano, and Andrea Perra
|
| 38749-38763 |
|
| A microfluidic approach towards hybridoma generation for cancer immunotherapy |
|
https://doi.org/10.18632/oncotarget.5550
Yen-Ta Lu, Gaurav Prashant Pendharkar, Chung-Huan Lu, Chia-Ming Chang, and Cheng-Hsien Liu
|
| 38764-38776 |
|
| Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors |
|
https://doi.org/10.18632/oncotarget.6091
Attje S. Hoekstra, Marieke A. de Graaff, Inge H. Briaire-de Bruijn, Cor Ras, Reza Maleki Seifar, Ivonne van Minderhout, Cees J. Cornelisse, Pancras C.W. Hogendoorn, Martijn H. Breuning, Johnny Suijker, Esther Korpershoek, Henricus P.M. Kunst, Norma Frizzell, Peter Devilee, Jean-Pierre Bayley, and Judith V.M.G. Bovée
|
| 38777-38788 |
|
| In vitro modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant EGFR mutants in nonsmallcell lung cancer |
|
https://doi.org/10.18632/oncotarget.5887
Toshiyuki Hirano, Hiroyuki Yasuda, Tetsuo Tani, Junko Hamamoto, Ayano Oashi, Kota Ishioka, Daisuke Arai, Shigenari Nukaga, Masayoshi Miyawaki, Ichiro Kawada, Katsuhiko Naoki, Daniel B. Costa, Susumu S. Kobayashi, Tomoko Betsuyaku, and Kenzo Soejima
|
| 38789-38803 |
|
| Association of the EGFTM7 receptor CD97 expression with FLT3ITD in acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.5661
Manja Wobus, Martin Bornhäuser, Angela Jacobi, Martin Kräter, Oliver Otto, Claudia Ortlepp, Jochen Guck, Gerhard Ehninger, Christian Thiede, and Uta Oelschlägel
|
| 38804-38815 |
|
| Deletion of cyclooxygenase2 inhibits Kras–induced lung carcinogenesis |
|
https://doi.org/10.18632/oncotarget.5558
Yong Pan, Yan Jiang, Lin Tan, Murali K. Ravoori, Mihai Gagea, Vikus Kundra, Susan M. Fischer, and Peiying Yang
|
| 38816-38826 |
|
| Biomarkerdriven stratification of diseaserisk in nonmetastatic medulloblastoma: Results from the multicenter HITSIOPPNET4 clinical trial |
|
https://doi.org/10.18632/oncotarget.5149
Steven C. Clifford, Birgitta Lannering, Ed C. Schwalbe, Debbie Hicks, Kieran O’ Toole, Sarah Leigh Nicholson, Tobias Goschzik, Anja zur Mühlen, Dominique Figarella-Branger, Franҫois Doz, Stefan Rutkowski, Göran Gustafsson, and Torsten Pietsch
|
| 38827-38839 |
|
| Synergistic antitumor efficacy against the EGFRvIII+HER2+ breast cancers by combining trastuzumab with antiEGFRvIII antibody CH12 |
|
https://doi.org/10.18632/oncotarget.6111
Wen Xu, Yanyu Bi, Jiqin Zhang, Juan Kong, Hua Jiang, Mi Tian, Kesang Li, Biao Wang, Cheng Chen, Fei Song, Xiaorong Pan, Bizhi Shi, Xianming Kong, Jianren Gu, Xiumei Cai, and Zonghai Li
|
| 38840-38853 |
|
| MDP a database linking drug response data to genomic information identifies dasatinib and statins as a combinatorial strategy to inhibit YAP/TAZ in cancer cells |
|
https://doi.org/10.18632/oncotarget.5749
Cristian Taccioli, Giovanni Sorrentino, Alessandro Zannini, Jimmy Caroli, Domenico Beneventano, Laura Anderlucci, Marco Lolli, Silvio Bicciato, and Giannino Del Sal
|
| 38854-38865 |
|
| Interleukin1 beta transactivates epidermal growth factor receptor via the CXCL1CXCR2 axis in oral cancer |
|
https://doi.org/10.18632/oncotarget.5640
Chia-Huei Lee, Shih-Han Syu, Ko-Jiunn Liu, Pei-Yi Chu, Wen-Chan Yang, Pinpin Lin, and Wan-Yu Shieh
|
| 38866-38880 |
|
| Characterization of novel biomarkers in selecting for subtype specific medulloblastoma phenotypes |
|
https://doi.org/10.18632/oncotarget.6195
Lisa Liang, Christopher Aiken, Robyn McClelland, Ludivine Coudière Morrison, Nazanin Tatari, Marc Remke, Vijay Ramaswamy, Magimairajan Issaivanan, Timothy Ryken, Marc R. Del Bigio, Michael D. Taylor, and Tamra E. Werbowetski-Ogilvie
|
| 38881-38900 |
|
| CD40 controls CXCR5induced recruitment of myeloidderived suppressor cells to gastric cancer |
|
https://doi.org/10.18632/oncotarget.5644
Yixin Ding, Jin Shen, Guangbo Zhang, Xiaojuan Chen, JiaMing Wu, and Weichang Chen
|
| 38901-38911 |
|
| Tunicamycin enhances the antitumor activity of trastuzumab on breast cancer in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.5334
Xiqian Han, Xiaobing Zhang, Hui Li, Shengshi Huang, Shu Zhang, Fengshan Wang, and Yikang Shi
|
| 38912-38925 |
|
| Potential role of aquaporin 3 in gastric intestinal metaplasia |
|
https://doi.org/10.18632/oncotarget.5370
Haijian Zhao, Xiaojun Yang, Yangchun Zhou, Weiming Zhang, Yao Wang, Jianfei Wen, Zhihong Zhang, and Lizong Shen
|
| 38926-38933 |
|
| Inhibition of cMYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells |
|
https://doi.org/10.18632/oncotarget.5380
Qiaoli Zhao, Andreana N. Assimopoulou, Sabine M. Klauck, Harilaos Damianakos, Ioanna Chinou, Nadine Kretschmer, José-Luis Rios, Vassilios P. Papageorgiou, Rudolf Bauer, and Thomas Efferth
|
| 38934-38951 |
|
| The BH3mimetic gossypol and noncytotoxic doses of valproic acid induce apoptosis by suppressing cyclinA2/Akt/FOXO3a signaling |
|
https://doi.org/10.18632/oncotarget.5731
Gao-Xiang Zhao, Li-Hui Xu, Hao Pan, Qiu-Ru Lin, Mei-Yun Huang, Ji-Ye Cai, Dong-Yun Ouyang, and Xian-Hui He
|
| 38952-38966 |
|
| Regulation of Aldoketoreductase family 1 B10 by 1433ε and their prognostic impact of hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.5734
Tzu-An Liu, Yee-Jee Jan, Bor-Sheng Ko, Yi-Ju Wu, Yi-Jhu Lu, Shu-Man Liang, Chia-Chia Liu, Shyh-Chang Chen, John Wang, Song-Kun Shyue, and Jun-Yang Liou
|
| 38967-38982 |
|
| Role of miR182 in response to oxidative stress in the cell fate of human fallopian tube epithelial cells |
|
https://doi.org/10.18632/oncotarget.5493
Yugang Liu, Wenan Qiang, Xiaofei Xu, Ruifen Dong, Alison M. Karst, Zhaojian Liu, Beihua Kong, Ronny I. Drapkin, and Jian-Jun Wei
|
| 38983-38998 |
|
| Identification of the βcatenin/JNK/prothymosinalpha axis as a novel target of sorafenib in hepatocellular carcinoma cells |
|
https://doi.org/10.18632/oncotarget.5738
Yi-Te Lin, and Chuck C.-K. Chao
|
| 38999-39017 |
|
| Neutropenia predicts better prognosis in patients with metastatic gastric cancer on a combined epirubicin oxaliplatin and 5fluorouracil regimen |
|
https://doi.org/10.18632/oncotarget.5730
Rujiao Liu, Mingzhu Huang, Xiaoying Zhao, Wei Peng, Si Sun, Jun Cao, Dongmei Ji, Chenchen Wang, Weijian Guo, Jin Li, Jiliang Yin, and Xiaodong Zhu
|
| 39018-39027 |
|
| NTRK1 rearrangement in colorectal cancer patients: evidence for actionable target using patientderived tumor cell line |
|
https://doi.org/10.18632/oncotarget.5494
Su Jin Lee, Gang Gary Li, Seung Tae Kim, Min Eui Hong, Jiryeon Jang, Nara Yoon, Soo Min Ahn, Danielle Murphy, Jason Christiansen, Ge Wei, Zachary Hornby, Dong Woo Lee, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Sung No Hong, Seok-Hyeong Kim, Won Ki Kang, Keunchil Park, Woong Yang Park, Kyoung-Mee Kim, and Jeeyun Lee
|
| 39028-39035 |
|
| Necrosis avid near infrared fluorescent cyanines for imaging cell death and their use to monitor therapeutic efficacy in mouse tumor models |
|
https://doi.org/10.18632/oncotarget.5498
Bangwen Xie, Marieke A. Stammes, Pieter B.A.A. van Driel, Luis J. Cruz, Vicky T. Knol-Blankevoort, Martijn A.M. Löwik, Laura Mezzanotte, Ivo Que, Alan Chan, Jeroen P.H.M. van den Wijngaard, Maria Siebes, Sven Gottschalk, Daniel Razansky, Vasilis Ntziachristos, Stijn Keereweer, Richard W. Horobin, Mathias Hoehn, Eric L. Kaijzel, Ermond R. van Beek, Thomas J.A. Snoeks, and Clemens W.G.M. Löwik
|
| 39036-39049 |
|
| RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration |
|
https://doi.org/10.18632/oncotarget.5176
Ila Datar, Xiaoliang Qiu, Hong Zhi Ma, Miranda Yeung, Shweta Aras, Ivana de la Serna, Fahd Al-Mulla, Jean Paul Thiery, Robert Trumbly, Xuan Fan, Hongjuan Cui, and Kam C. Yeung
|
| 39050-39061 |
|
| IGK with conserved IGΚV/IGΚJ repertoire is expressed in acute myeloid leukemia and promotes leukemic cell migration |
|
https://doi.org/10.18632/oncotarget.5393
Chong Wang, Miaoran Xia, Xiaoping Sun, Zhiqiao He, Fanlei Hu, Lei Chen, Carlos E. Bueso-Ramos, Xiaoyan Qiu, and Cameron C. Yin
|
| 39062-39072 |
|
| Simple and rapid determination of homozygous transgenic mice via in vivo fluorescence imaging |
|
https://doi.org/10.18632/oncotarget.5535
Xiaolin Lin, Junshuang Jia, Yujuan Qin, Xia Lin, Wei Li, Gaofang Xiao, Yanqing Li, Raoying Xie, Hailu Huang, Lin Zhong, Qinghong Wu, Wanshan Wang, Wenhua Huang, Kaitai Yao, Dong Xiao, and Yan Sun
|
| 39073-39087 |
|
| Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and metaanalysis |
|
https://doi.org/10.18632/oncotarget.5142
Claudio Luchini, Nicola Veronese, Marco Solmi, Hanbyoul Cho, Jae-Hoon Kim, Angela Chou, Anthony J. Gill, Sheila F. Faraj, Alcides Chaux, George J. Netto, Kentaro Nakayama, Satoru Kyo, Sun Young Lee, Duck-Woo Kim, George M. Yousef, Andreas Scorilas, Gregg S. Nelson, Martin Köbel, Steve E. Kalloger, David F. Schaeffer, Hai-Bo Yan, Feng Liu, Yoshihito Yokoyama, Xianyu Zhang, Da Pang, Zsuzsanna Lichner, Giuseppe Sergi, Enzo Manzato, Paola Capelli, Laura D. Wood, Aldo Scarpa, and Christoph U. Correll
|
| 39088-39097 |
|
| An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype |
|
https://doi.org/10.18632/oncotarget.5390
Ming-Kai Chuang, Yu-Chiao Chiu, Wen-Chien Chou, Hsin-An Hou, Mei-Hsuan Tseng, Yi-Yi Kuo, Yidong Chen, Eric Y. Chuang, and Hwei-Fang Tien
|
| 39098-39110 |
|
| Oncogenic features of the bone morphogenic protein 7 BMP7 in pheochromocytoma |
|
https://doi.org/10.18632/oncotarget.4912
Ines Leinhäuser, Andrea Richter, Misu Lee, Ines Höfig, Nataša Anastasov, Falko Fend, Tonino Ercolino, Massimo Mannelli, Anne-Paule Gimenez-Roqueplo, Mercedes Robledo, Ronald de Krijger, Felix Beuschlein, Michael J. Atkinson, and Natalia S. Pellegata
|
| 39111-39126 |
|
| Prognostic microRNAs modulate the RHO adhesion pathway: A potential therapeutic target in undifferentiated pleomorphic sarcomas |
|
https://doi.org/10.18632/oncotarget.3926
Philip Wong, Angela Hui, Jie Su, Shijun Yue, Benjamin Haibe-Kains, Nalan Gokgoz, Wei Xu, Jeff Bruce, Justin Williams, Charles Catton, Jay S. Wunder, Irene L. Andrulis, Rebecca Gladdy, Brendan Dickson, Brian O’Sullivan, and Fei-Fei Liu
|
| 39127-39139 |
|
| Gemcitabine triggers angiogenesispromoting molecular signals in pancreatic cancer cells: Therapeutic implications |
|
https://doi.org/10.18632/oncotarget.3784
Mohammad Aslam Khan, Sanjeev K. Srivastava, Arun Bhardwaj, Seema Singh, Sumit Arora, Haseeb Zubair, James E. Carter, and Ajay P. Singh
|
| 39140-39150 |
|
| SubpathwayGMir: identifying miRNAmediated metabolic subpathways by integrating conditionspecific genes microRNAs and pathway topologies |
|
https://doi.org/10.18632/oncotarget.5341
Li Feng, Yanjun Xu, Yunpeng Zhang, Zeguo Sun, Junwei Han, Chunlong Zhang, Haixiu Yang, Desi Shang, Fei Su, Xinrui Shi, Shang Li, Chunquan Li, and Xia Li
|
| 39151-39164 |
|
| miRNAs in multiple myeloma – a survival relevant complex regulator of gene expression |
|
https://doi.org/10.18632/oncotarget.5381
Anja Seckinger, Tobias Meißner, Jérôme Moreaux, Vladimir Benes, Jens Hillengass, Mirco Castoldi, Jürgen Zimmermann, Anthony D. Ho, Anna Jauch, Hartmut Goldschmidt, Bernard Klein, and Dirk Hose
|
| 39165-39183 |
|
| Effects of interferons and doublestranded RNA on human prostate cancer cell apoptosis |
|
https://doi.org/10.18632/oncotarget.5508
Haiyan Tan, Chun Zeng, Junbo Xie, Norah J. Alghamdi, Ya Song, Hongbing Zhang, Aimin Zhou, and Di Jin
|
| 39184-39195 |
|
| Bladder cancer cells reeducate TAMs through lactate shuttling in the microfluidic cancer microenvironment |
|
https://doi.org/10.18632/oncotarget.5538
Yang Zhao, Degui Wang, Ting Xu, Pengfei Liu, Yanwei Cao, Yonghua Wang, Xuecheng Yang, Xiaodong Xu, Xinsheng Wang, and Haitao Niu
|
| 39196-39210 |
|
| REC8 is a novel tumor suppressor gene epigenetically robustly targeted by the PI3K pathway in thyroid cancer |
|
https://doi.org/10.18632/oncotarget.5391
Dingxie Liu, Xiaopei Shen, Guangwu Zhu, and Mingzhao Xing
|
| 39211-39224 |
|
| miR454 functions as an oncogene by inhibiting CHD5 in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.4407
Lei Yu, Xuejun Gong, Lei Sun, Hong Yao, Baoling Lu, and Liying Zhu
|
| 39225-39234 |
|
| NOX5L can stimulate proliferation and apoptosis depending on its levels and cellular context determining cancer cell susceptibility to cisplatin |
|
https://doi.org/10.18632/oncotarget.5743
So Hee Dho, Ji Young Kim, Eun-Soo Kwon, Jae Cheong Lim, Sung Sup Park, and Ki-Sun Kwon
|
| 39235-39246 |
|
| Depletion of the thiol oxidoreductase ERp57 in tumor cells inhibits proliferation and increases sensitivity to ionizing radiation and chemotherapeutics |
|
https://doi.org/10.18632/oncotarget.5746
Melanie Hussmann, Kirsten Janke, Philip Kranz, Fabian Neumann, Evgenija Mersch, Melanie Baumann, Kirsten Goepelt, Ulf Brockmeier, and Eric Metzen
|
| 39247-39261 |
|
| NFκB contributes to MMP1 expression in breast cancer spheroids causing paracrine PAR1 activation and disintegrations in the lymph endothelial barrier in vitro |
|
https://doi.org/10.18632/oncotarget.5741
Chi Huu Nguyen, Daniel Senfter, Jose Basilio, Silvio Holzner, Serena Stadler, Sigurd Krieger, Nicole Huttary, Daniela Milovanovic, Katharina Viola, Ingrid Simonitsch-Klupp, Walter Jäger, Rainer de Martin, and Georg Krupitza
|
| 39262-39275 |
|
| A803467 a tetrodotoxinresistant sodium channel blocker modulates ABCG2mediated MDR in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.5747
Nagaraju Anreddy, Atish Patel, Yun-Kai Zhang, Yi-Jun Wang, Suneet Shukla, Rishil J. Kathawala, Priyank Kumar, Pranav Gupta, Suresh V. Ambudkar, John N. D. Wurpel, Zhe-Sheng Chen, and Huiqin Guo
|
| 39276-39291 |
|
| Evaluation of pentacyclic triterpenes found in Perilla frutescens for inhibition of skin tumor promotion by 12Otetradecanoylphorbol13acetate |
|
https://doi.org/10.18632/oncotarget.5751
Jiyoon Cho, Lisa Tremmel, Okkyung Rho, Andrew M. Camelio, Dionicio Siegel, Thomas J. Slaga, and John DiGiovanni
|
| 39292-39306 |
|
| Stromal cells promote antiestrogen resistance of breast cancer cells through an insulinlike growth factor binding protein 5 IGFBP5/Bcell leukemia/lymphoma 3 Bcl3 axis |
|
https://doi.org/10.18632/oncotarget.5624
Benjamin Leyh, Angela Dittmer, Theresia Lange, John W. M. Martens, and Jürgen Dittmer
|
| 39307-39328 |
|
| Suppression of mTOR pathway and induction of autophagydependent cell death by cabergoline |
|
https://doi.org/10.18632/oncotarget.5744
Shao Jian Lin, Zhi Gen Leng, Yu Hang Guo, Lin Cai, Yu Cai, Ning Li, Han Bing Shang, Wei-Dong Le, Wei Guo Zhao, and Zhe Bao Wu
|
| 39329-39341 |
|
| Celecoxib increases lung cancer cell lysis by lymphokineactivated killer cells via upregulation of ICAM1 |
|
https://doi.org/10.18632/oncotarget.5745
Melina Schellhorn, Maria Haustein, Marcus Frank, Michael Linnebacher, and Burkhard Hinz
|
| 39342-39356 |
|
| The diagnostic and prognostic value of MRP8/MRP14 in intrahepatic cholangiocarcinoma |
|
https://doi.org/10.18632/oncotarget.5329
Guang-Zhi Jin, Wei Dong, Hui Dong, Hua Yu, Jia Chen, Wen-Long Yu, Ai-Jun Li, Wen-Ming Cong, and Meng-Chao Wu
|
| 39357-39364 |
|
| Efficacy and safety of capecitabinebased firstline chemotherapy in advanced or metastatic breast cancer: a metaanalysis of randomised controlled trials |
|
https://doi.org/10.18632/oncotarget.5460
Weijiao Yin, Guangsheng Pei, Gang Liu, Li Huang, Shegan Gao, and Xiaoshan Feng
|
| 39365-39372 |
|
| Prognostic score models for survival of nasopharyngeal carcinoma patients treated with intensitymodulated radiotherapy and chemotherapy |
|
https://doi.org/10.18632/oncotarget.5781
Lei Zeng, Pi Guo, Jin-Gao Li, Fei Han, Qiang Li, Yong Lu, Xiao-Wu Deng, Qing-Ying Zhang, and Tai-Xiang Lu
|
| 39373-39383 |
|
| Erratum: Changes in expression levels of ERCC1 DPYD and VEGFA mRNA after firstline chemotherapy of metastatic colorectal cancer: results of a multicenter study |
|
https://doi.org/10.18632/oncotarget.6335
Hideo Baba, Yoshifumi Baba, Shinji Uemoto, Kazuhiro Yoshida, Akio Saiura, Masayuki Watanabe, Yoshihiko Maehara, Eiji Oki, Yasuharu Ikeda, Hiroyuki Matsuda, Masakazu Yamamoto, Mitsuo Shimada, Akinobu Taketomi, Michiaki Unno, Kenichi Sugihara, Yutaka Ogata, Susumu Eguchi, Seigo Kitano, Kazuo Shirouzu, Yasumitsu Saiki, Hiroshi Takamori, Masaki Mori, Toshihiko Hirata, Go Wakabayashi, and Norihiro Kokudo
|
| 39384-39384 |
